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Assessment of Pulmonary Edema: Principles and Practice 
 
Abstract:  
Pulmonary edema is increasingly recognized as a perioperative complication 
impacting outcome. Several risk factors have been identified including those of 
cardiogenic origin, such as heart failure or excessive fluid administration, as well as 
those related to increased pulmonary capillary permeability secondary to inflammatory 
mediators.  
Effective treatment requires prompt diagnosis and early intervention.  
Consequently, the past two centuries have seen a concentrated effort to develop clinical 
tools to rapidly diagnose pulmonary edema and track response to treatment. The ideal 
properties of which include high sensitivity and specificity, easy availability, and the 
ability to diagnose early accumulation of lung water prior to the development of the full 
clinical presentation.  In addition, clinicians highly value the ability to precisely quantify 
extravascular lung water accumulation and differentiate hydrostatic from high 
permeability etiologies of pulmonary edema.   
In this review, we first discuss advances in understanding the physiology of 
extravascular lung water accumulation in health and in disease and the various 
mechanisms that protect against development of pulmonary edema under physiologic 
conditions. We then examine the various bedside modalities available to diagnose early 
accumulation of extravascular lung water and pulmonary edema including chest 
auscultation, chest roentgenography, lung ultrasonography and transpulmonary 
thermodilution. We explore the advantages and limitations of these methods for the 
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operating room and intensive care which are critical for proper modality selection in 
each individual case.  
Introduction:  
The lungs represent a unique organ in which air and blood are circulating 
efficiently, each in its own conduit without mixing with one another. Air circulates in its 
bronchial and alveolar conduits surrounded by blood circulating in a permeable and 
pressurized capillary network. Normally there is a balance between the net fluid filtered 
from the pulmonary circulation and the fluid absorbed by the lymphatic system. This 
balance ensures only a small volume of fluid is present in the interstitial space. 
Excessive accumulation of extravascular lung water (EVLW) is clinically manifested as 
pulmonary edema.  This can result from an increase in the amount of filtered fluid 
secondary to marked increases in pulmonary hydrostatic pressure or an increase in the 
pulmonary capillary permeability, which causes water and proteins extravasation 1 or 
from interruption of the lymphatic drainage as in lung resection surgery 2. Regardless of 
the etiology, the resultant fluid accumulation in the lung impairs respiratory gas 
exchange resulting in respiratory distress and the need for mechanical ventilation. 
Pulmonary edema is increasingly recognized as a perioperative complication 
impacting outcome. Several factors have been identified e.g. fluid overload, systemic 
inflammatory response to surgery, myocardial ischemia, blood product transfusion, etc., 
all of which contribute to increased fluid transudation and accumulation of extravascular 
lung water 3 . Management strategies directed at avoiding excessive fluid administration 
(e.g. goal directed fluid therapy) or reducing inflammatory response (e.g. protective lung 
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ventilation to avoid ventilator induced lung injury) are commonly advocated in 
perioperative care protocols 1, 4-6 7.  
Furthermore, pulmonary edema represents a significant burden to the healthcare 
system.  A review of 8195 patients who underwent major inpatient operations in two 
university teaching hospitals revealed an incidence of pulmonary edema of 7.6% with 
an associated in hospital mortality rate of 11.9% 8. Pulmonary edema is associated with 
higher morbidity rates and prolonged intensive care (ICU) stay, in which 15% will 
require mechanical ventilation 9. Further, the addition of mechanical ventilation will 
extend the length of stay in the ICU 10. As such this complication often results in a lose-
lose proposition as it worsens patient outcomes while greatly increasing healthcare 
costs 11.   
For decades, chest auscultation and roentgenography played a major role to 
diagnose pulmonary edema and monitor response to therapy. Our understanding of the 
inherent limitations of these two methods has led to the development of newer 
technologies that offer more sensitive detection of lung water changes in real time to 
better aid diagnosis and guide clinical interventions 12.  Of these, both the lung 
ultrasound (LUS) and transpulmonary thermodilution (TPTD) methods have now 
entered the clinical arena. The aim of this review is to provide an up to date examination 
of the recent advances in understanding the physiology of lung water dynamics in 
health and disease and to highlight the various bedside methods available to measure 
EVLW and diagnose pulmonary edema.  There is special emphasis on the emerging 
role of LUS and TPTD as new tools to quantitatively measure EVLW in the perioperative 
period and provide early diagnosis of pulmonary edema. 
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Current Concepts in Pulmonary Fluid Dynamics 
Extravascular Lung Water in Health and Disease:  
It is a remarkable feat of engineering that prevents the air-filled alveoli and 
surrounding interstitium from being soaked by the neighboring pulmonary vessels.  
Pressurized and highly permeable, there is a strong motive force driving pulmonary 
capillary fluids across the microvascular endothelium into the interstitium and air sacs.  
Yet the interstitium is a relatively dry space with EVLW value of < 10 ml per kg of ideal 
body weight 13 . 
 The mechanism controlling fluid exchange between the microvascular and 
interstitial spaces proposed by Ernest Starling in 1896 shaped medical thinking for over 
a century. He concluded that the interplay of outward filtration forces created by the 
capillary hydrostatic pressure and the inward reabsorption forces from plasma protein 
oncotic pressure determined fluid exchange with the capillary endothelium acting as a 
semipermeable membrane 14.  
Although this model became widely adopted as doctrine, a series of experimental 
data beginning in the 1940’s raised doubts on its merit. The discovery that an 
endothelial surface layer lining the luminal side of the capillary endothelium, as first 
predicted by Danielli 1940 15, and the non-linear relationship between hydrostatic 
pressure and vascular permeability, which represents a deviation from the classic 
Starling relationship, revolutionized the understanding of fluid dynamics 16-18. 
Electron microscopy shows that the endothelial surface layer is lined with a 
complex network of glycosaminoglycans and proteins, which creates a gel like coating.  
The structure of this endothelial surface layer is called the endothelial glycocalyx (figure 
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1) 19. This glycocalyx layer (EG) has recently been discovered to play a critical role in 
capillary fluid dynamics preventing excessive fluid extravasation.  First, it acts as a 
molecular sieve limiting water and solute efflux across the intercellular junction. Second, 
it provides scaffolding upon which serum plasma proteins accumulate and consequently 
a layer of ultrafiltrate is created between the endothelium and the EG. This layer of 
ultrafiltrate creates a powerful oncotic force pulling fluid to the intravascular 
compartment. Breakdown of this layer, such as following surgical trauma and 
ischemic/reperfusion injuries, results in markedly increased capillary permeability 
(Figure 2) 17. Lastly, the EG acts as a mechanosensor transmitting the shear stress from 
blood flow to the endothelium cytoskeleton initiating intracellular signaling which 
increases capillary permeability 16, 20.   Following a marked increase in capillary 
hydrostatic pressure, fluid extravasates out of the capillaries and accumulates in the 
interstitial space.   
The emerging role of the EG has reshaped our current understanding of the 
pathophysiology of pulmonary edema. Either damage to this EG layer or marked 
increases in capillary hydrostatic pressure will lead to excessive fluid transudation into 
the interstitial space.  
 
Role of pulmonary capillary pressure and hydrostatic edema: 
The pulmonary capillary wedge pressure or left atrial pressure are clinically used 
as indicators of the pressure in the pulmonary microvasculature although they are not 
the same as the pulmonary capillary hydrostatic pressure.  The relationship between 
pulmonary microvascular hydrostatic pressure and left atrial pressure can be estimated 
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by the following equation: Pmv = PLa + 0.4 (MPAP - PLa)                                                                               
Where Pmv  is the Pulmonary microvascular hydrostatic pressure, PLa  is left atrial 
pressure and MPAP is mean pulmonary pressure 21. 
To mitigate EVLW accumulation following increases in capillary hydrostatic 
pressure and cardiac output, the pulmonary circulation exhibits several protective 
mechanisms namely, recruitment and distention of the pulmonary capillaries22.  In an 
animal model, it was found that the extravascular lung water accumulation did not 
change significantly until microvascular hydrostatic pressure more than doubled; 
supporting a wide safety margin against rises in microvascular hydrostatic pressure 21, 
23. However, conditions associated with further rise in hydrostatic pressure, such as 
excessive fluid administration or heart failure can overwhelm these mechanisms 
resulting in fluid extravasation and pulmonary edema. 
Role of lymphatics in fluid clearance: 
The pulmonary lymphatics are present along the peribronchovascular, 
interlobular septae and the pleural spaces. These loose connective tissue spaces serve 
as a sump suction system draining fluid away from the alveolar interstitium in early 
stages of EVLW accumulation 24. The effectiveness of this lymphatic sump drainage 
was demonstrated by Zarines et al., who showed that the lymph flow is about 20 ml/hr 
under normal conditions and increases 5-10 fold with chronic elevations in interstitial 
pressure 25. Gee and Williams determined that water content contained by the 
peribronchiovascular cuffs increased 70% when transpulmonary pressure was 
increased to 20 cmH20 26.  Further accumulation of interstitial fluid is limited by the low 
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compliance of the interstitial compartment. This protective mechanism is short-lived 
secondary to fragmentation of interstitial proteoglycans causing loss of matrix integrity27. 
Progression to Pulmonary Edema: 
Whether a result of increases in hydrostatic forces or increases in permeability, 
fluid accumulation progresses in a defined sequence. In stage 1 (“compensated”), fluid 
accumulation increases but is balanced by the increase in lymphatic flow causing no net 
accumulation of fluids. Stage 2 (“perihilar edema”) develops when the lymphatic flow is 
overwhelmed by the increase in fluid accumulation and edema starts to develop 
surrounding the bronchioles and lung vasculature yielding the classic roentgenographic 
pattern of interstitial pulmonary edema (Kerley B lines, indistinct vessels, peribronchial 
cuffing, and). Stage 3 (“alveolar edema”) develops following further accumulation of 
interstitial fluid which tracks first around the periphery of the alveolar membrane (stage 
3a) and finally disrupting the alveolar wall causing alveolar flooding (stage 3b) which 
results in impairment in the gas exchange yielding the roentgenographic picture of 
alveolar pulmonary edema 28. The ability to track the progression of lung water 
accumulation as well as to determine its causative etiology remains the Holy Grail for 
clinical assessment of pulmonary edema. 
 
Clinical Techniques to assess extravascular lung water: 
Auscultation: 
Although symptoms and signs of the patient examination (tachypnea, orthopnea) 
can suggest pulmonary edema, it wasn’t until the advent of chest auscultation, and later 
the development of the stethoscope, that clinicians had a more objective means to 
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assess lung edema.  Auscultation remains a highly valued diagnostic tool in wide use 
today despite the development of more sophisticated technologies. The ability to 
diagnose different lung diseases by chest auscultation was initially explored by 
Hippocrates who placed his ears directly on the patient’s chest to hear transmitted 
sounds and called this procedure “direct auscultation”. The development of the 
stethoscope, first using a rolled paper cone and later a hollow wooden tube, by the 
French physician Dr. René Laënnec in the 19th century brought auscultation into the 
focus of clinical practice (Figure 3) 29. Laennec, through extensive medical practice was 
the first to classify different breath sounds, which he then determined to be 
pathognomonic of pulmonary pathologies including pneumonia, bronchiectasis and 
pulmonary edema.  In his landmark publication, “A Treatise on the Diseases of the 
Chest and on Mediate Auscultation”, he described the classic auscultatory findings in 
pulmonary edema as deep crepitus inspiratory râles which convey the impression of air 
entering and distending dry lungs 30.  
 Râles, a term that has been replaced by “crackles” in modern practice, remain 
the key diagnostic feature of auscultation in pulmonary edema.  These are 
discontinuous, explosive and nonmusical adventitious sounds normally heard in 
inspiration. They are classified according to their duration, loudness and timing in the 
respiratory cycle as fine or coarse crackles (Figure 4) 31. Importantly fine crackles are 
produced within small airways often impacted by interstitial edema whereas coarse 
crackles arise from large bronchi in processes such as pneumonia 32.  The mechanism 
of production of fine crackles is the snap opening of small airways during inspiration 
after being collapsed during expiration. In cardiogenic pulmonary edemas, crackles 
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occur due to opening of the small airways narrowed by peribronchial edema 33. They 
are detected as high pitched, long duration sounds beginning in late inspiration. They 
are typically best appreciated in posterior basal regions in supine patients.  
 The stethoscope is an inexpensive, accessible bedside tool that has been in 
common practice for over a century, despite significant limitations of its usefulness. 
These limitations include wide inter-observer variability, inadequate understanding of 
the mechanism of sound production in different pathologies, failure to detect lung water 
accumulation in its early phases, and difficulty in monitoring the progression of the 
disease 34. In a study on acute respiratory distress syndrome (ARDS) patients, lung 
auscultation had a diagnostic accuracy of 55% compared to thoracic computed 
tomography 35. It was also shown to have a very low power to discriminate mild and 
moderate pulmonary congestion when compared to lung ultrasound in patients with end 
stage renal disease on hemodialysis36. 
 Clinician’s hearing loss due to increasing age or disease is an additional limitation of 
stethoscopy 37.  Stethoscopes compatible with hearing aids and electronic stethoscopes 
using sophisticated mathematical models have been introduced into clinical practice in 
an attempt to overcome some of the limitations and improve its sensitivity and specificity 
for lung water detection 38, 39.  
The stethoscope remains an important part of the physical examination, but 
because of its shortfalls, it is becoming a decorative instrument for many practitioners 
who increasingly rely on more sensitive and reliable technologies. 
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Chest Roentgenography: 
 The chest roentgenogram has been relied on to diagnose and follow the 
progression of pulmonary edema for decades. It quickly established itself as the 
standard reference technique against which other methods to measure lung water 
content were compared. It offers the advantages of being widely available, reproducible, 
noninvasive, portable and relatively low in cost.  
Standard imaging utilizes the postero-anterior and lateral views, or in the case of 
portable exams, the anteroposterior view. Interstitial features of pulmonary edema 
manifest radiographically as peribronchial cuffing, indistinct vessels, and septal (Kerley) 
lines (Figure 5).  In distinction, alveolar features present with acinar opacities, ground 
glass opacities, and frank consolidations (Figure 6). The appearance of these features 
along with patterns of distribution and other accompanying findings can be used as 
clues to the cause and severity of the pulmonary edema. Table 1 highlights the 
radiographic findings associated with disease severity. For example, stage 2 pulmonary 
edema appears as a perihilar process while the more severe stage 3 appears as a 
generalized flooding of the lung fields 40-43. 
Radiologists often seek out a pattern of chest roentgenogram findings to 
differentiate between cardiogenic (e.g., congestive heart failure, CHF), noncardiogenic 
(e.g., ARDS), and fluid overload (e.g., renal failure) causes of edema (Table 2) 44, 45. 
Using these chest roentgenogram features, Milne et al showed an average of 91% 
accuracy in distinguishing capillary permeability edema from other varieties, and 81% 
accuracy in distinguishing cardiogenic edema from that of renal failure 44.   
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Gluecker et al offered further insight into radiographic patterns to allow 
differentiation between a myriad of causes of pulmonary edema.  For example, the 
bilateral perihilar alveolar edema appearance “bat-wing” in patients with acute severe 
CHF or renal failure that can improve rapidly with aggressive treatment. Septal lines, 
peribronchial cuffing and, if severe, alveolar edema are markers for negative pressure 
or post obstructive edema. Kerley lines, peribronchial cuffing and patchy perihliar 
airspace consolidation are seen in near-drowning cases. Bilateral homogeneous 
airspace consolidation favoring upper lobes is typical of neurogenic edema. Central 
interstitial edema (peribronchial cuffing, indistinct vessels) and asymmetrical patchy 
airspace consolidation are findings in high-altitude edema. A spectrum from modest 
interstitial (Kerley lines, peribronchial cuffing and indistinct vessels) to severe alveolar 
(consolidation) is seen in postpneumonectomy edema 42.  Accordingly, the ability of 
chest roentgenogram patterns to differentiate pathology and predict response to therapy 
is highly valued in the clinical setting. 
From a physiological standpoint, radiographic features of acute cardiogenic 
pulmonary edema generally correlate with the pulmonary capillary wedge pressures. 
The chest roentgenogram can be normal with mildly elevated pressures, but with 
increasing pressures and fluid transudation, various features become evident 42,43. Early 
on, in cardiac compromise and/or volume overload, radiographic findings of enlarged 
heart, engorged upper lobe vessels, or widened vascular pedicle are considered “pre-
edema” features.  With progressive EVLW accumulation, the chest roentgenogram 
typically begins to show features associated with pulmonary edema (e.g., Kerley lines, 
indistinct vessels, peribronchial cuffing, and airspace opacities).    
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Despite these advantages, the clinical environment has shown substantial 
limitations with chest roentgenographic monitoring.  For example, the well described 
relationship between pathology and imaging has a clinical correlation that is less than 
desired 46, 47.  In addition, there is often a time lag of up to 12 hours after the clinical and 
physiological manifestations of CHF to the appearance of radiographic findings due to 
the relatively slow movement of water through the widened capillary endothelial cell 
junction.  Similarly, with resolution of pulmonary edema, the radiographic findings will 
persist for 1 to 4 days after the physiologic and clinical improvement 46.  Limitations in 
accuracy also must be considered. In the diagnosis of alveolar-interstitial pulmonary 
edema the accuracy of chest roentgenogram was shown to be only 72% compared to 
computed tomography in a case-control study 35. In a study of ARDS patients, chest 
roentgenogram was modestly correlated with transpulmonary thermodilution measured 
EVLW. The authors noted chest roentgenogram lacked quantitative measurement of 
EVLW that can be advantageous to guide fluid management and was insensitive to 
detection of small changes in EVLW and failed to predict mortality compared to 
transpulmonary thermodilution 48. In an animal study, chest radiography did not detect 
EVLW until lung water had increased by > 35% 49. Although, chest roentgenogram was 
able to distinguish temporal changes in lung water in critically ill patients randomized to 
receive a diuretic or placebo 50, it failed to accurately monitor modest changes in lung 
water 51.  
The degree of interobserver variation in chest roentgenography represents 
another concern. In a study of 21 expert radiologists selected to review 28 chest 
radiographs of ARDS patients under mechanical ventilation, the interobserver variability 
 13 
ranged from 36 to 71% in diagnosing ARDS according to the American-European 
consensus Conference definition of ARDS 52.  Many anesthesiologists practicing in 
intensive care units make important clinical decisions guided by radiographic 
interpretations. Given the challenges faced by radiologists, it is no surprise the 
radiographic interpretation in patients with significant pulmonary diseases can exceed 
the skills of many anesthesiologists 53.   
The suboptimal quality of portable images is another disadvantage, which 
particularly impacts perioperative and critical care clinicians. In portable, supine 
radiographs, the evaluation of heart and vessel size is limited, however, alveolar and 
interstitial edema, and possibly pleural effusions, can still be evaluated.  Similarly, chest 
fluoroscopy is not preferred to evaluate for pulmonary edema because its fidelity for 
assessment of fluid accumulation is even inferior to that of a portable chest radiograph 
(e.g., evaluation of pulmonary vessels, bronchial walls, interstitial lines, etc.) 54.  In 
current practice the use of fluoroscopy is out of favor as the digital chest radiograph can 
be obtained portably and is almost instantly available for review.   
Regardless of technique, chest roentgenography lacks the fidelity obtained with 
computed tomography (CT) where the extent and characterization of airspace disease 
(ground glass opacity and consolidation) is more vividly portrayed, as are certain 
interstitial features such as septal lines and pleural effusions.  And although the 
radiation exposure of a chest roentgenogram is far less than that of CT, cumulative 
radiation exposure with repeated examinations remains a concern. 
Despite these shortfalls, chest roentgenography continues to be widely used as a 
tool to monitor pulmonary edema in intensive care units. However, clinical desire for 
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more accurate and timely guidance of fluid therapy and more sensitive detection of early 
lung water changes are leading to the adoption of newer technologies. 
 
Lung Ultrasonography: 
Lung Ultrasound (LUS) has become a valuable point of care (POC) tool in the 
assessment of acute pulmonary pathologies in the intensive care unit, emergency 
department, and operating room. Based on visualization of anatomical structures, 
pathological findings, and acoustic artifacts, specific image patterns can be identified for 
the differentiation of a variety of pulmonary- and pleural disease-states 55. While healthy 
lung tissue is poorly penetrated by ultrasound due to the high acoustic impedance of air, 
the presence of EVLW results in occurrence of so-called B-lines or lung comets which 
are formed as a result of acoustic reverberation artifacts arising from the air-fluid 
interface between collapsed, fluid-filled, and aerated alveoli 56, 57.  
First described in 1982 58, specific characteristics distinguish B-lines from other 
artifacts seen on LUS, and they represent the core-imaging finding used in the 
evaluation of pulmonary edema. Sonographic appearance of normal lung tissue is 
defined by “black” lung with sliding movement of visceral and parietal pleura against 
each other, and horizontal reverberation artifact of the pleural line in equal distance 
termed A-lines as shown in video 1. 
B-lines are well-defined, hyperechoic artifacts, arising from the pleural line 
fanning down into the far field of the screen without fading (Figure 7). While healthy lung 
tissue may display 3-4 B-lines correlating with radiographic Kerley B-lines, the presence 
of more than three B-lines (also called lung rockets) is indicative of interstitial edema. 
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With further increase in EVLW, a rising number of B-lines are seen in narrower distance 
apart, and they can merge to display ground glass rockets, also called “white lung”, 
seen in severe states of alveolar-interstitial syndrome (AIS) (Figure 8) 59. Sonographic 
appearance of AIS can be seen with multiple underlying pathologies such as 
cardiogenic pulmonary edema (APE), acute respiratory distress syndrome (ARDS), or 
pulmonary fibrosis, and only identification of AIS on LUS in conjunction with other 
pathologic image-patterns enables the skilled sonographer to differentiate these 
etiologies (Table 3) 60. AIS in the setting of left atrial hypertension and increased 
hydrostatic pressure often shows a uniform distribution pattern of B-lines, with normal 
lung sliding and a high incidence of homogeneous appearing pleural effusions. In 
contrast, ultrasound findings suggestive of ARDS include increased amounts of B-lines 
seen in combination with pleural line abnormalities, lack of lung sliding, uneven tissue 
patterns like “spared areas” and consolidations and consolidation-associated findings 
such as “lung pulse” (which is defined as the absence of lung sliding with the 
perception of heart activity at the pleural line) and air-bronchograms (Figure 9).   
When pattern-recognition is used in an algorithmic approach like the Bedside 
Lung Ultrasound in Emergency (BLUE) protocol, LUS has a diagnostic accuracy of  
> 95% sensitivity and specificity for a broad variety of pulmonary and pleural 
pathologies 61, 62. This contrasts with chest roentgenogram or clinical examination 
including auscultation or both that showed a sensitivity of 7- 14 % in patients with 
documented AIS by LUS in the perioperative period of cardiac surgery 63. 
The correlation of B-line artifacts as a marker of increased EVLW show similar high 
accuracy with sensitivities and specificities of > 90% when compared to multiple classic 
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methods of assessing EVLW like computed tomography of the chest 62, 64, chest 
roentgenogram 35, 65, pulmonary occlusion pressures 66, 67, brain natriuretic peptide 
(BNP) measurements 68, or transpulmonary thermodilution (TPTD) method to measure 
EVLW 66. In addition, the linear correlation between quantity of B-lines, amount of 
EVLW, and clinical pulmonary edema has been well recognized, and application of 
quantitative algorithms, like lung comet scores, may provide a useful clinical tool in the 
daily POC assessment for pulmonary edema 65, 66, 69.  
Over the last decade multiple studies have established good temporal correlation 
between amount of EVLW and the onset and resolution of B-lines 65, 66, 70. In addition, 
Caltabeloti et al found that loss in lung aeration in septic patients receiving fluid-
resuscitation, could be detected by LUS within a 40-minute timeframe, even before 
changes in oxygenation by partial pressure of arterial oxygen to fraction of inspired 
oxygen (PaO2/FiO2) ratio 71. Furthermore, the immediate dynamic changes of B-lines in 
correlation to volume removal in patients while undergoing hemodialysis was shown in 
renal failure patients undergoing hemodialysis 72, 73. These findings confirm the clinical 
advantage of LUS in the immediate and dynamic feedback of severity of pulmonary 
edema when compared to chest radiograph. 
The clinical use of LUS in evaluating increases in EVLW is ample. It ranges from 
initial POC diagnostic for respiratory failure to guidance of patient care, to finally, follow-
up monitoring of performed clinical interventions. Currently the overwhelming use 
remains in the diagnosis and management of respiratory failure and guidance in volume 
resuscitation. Standardized algorithms used for the assessment of EVLW and lung 
pathologies optimize sensitivity and specificity while making it a fast and practical tool in 
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the daily clinical management 69, 74, 75. In a study of patients undergoing cardiac surgery, 
the combined use of transthoracic echocardiography and lung ultrasound was shown to 
change the clinical management in 67% of the patients. Furthermore, lung ultrasound 
was able to detect alveolar-interstitial disease that was missed by clinical examination 
and chest roentgenography 76.  
Utilizing 5-13 MHz linear array, or 1 – 6 MHz phased array ultrasound probes, 
multimodal scanning of the anterior and lateral lung at different locations is applied to 
achieve a panoramic impression of the complete lung and pleura 77. While most of the 
literature focuses on the advantages, accuracy, and feasibility of LUS for the diagnosis 
of pulmonary edema and other pathologies, little data has been published on outcomes 
when used to guide patient management. One study by Frassi et al, showed that LUS is 
a more powerful predictor for significant events in patients with symptoms of dyspnea or 
chest pain on hospital admission than echocardiographic variables 78. Additionally, 
Soummers et al suggested a predictive value of LUS in the weaning process from 
mechanical ventilation. In their study, B-lines predominance were associated with 
increased respiratory failure post extubation 79. 
The advantages of LUS as an economic, fast, and real-time imaging modality for 
diagnosis and surveillance of clinical relevant pathologies has positioned the technique 
at the center of POC diagnostics in critical care medicine, emergency medicine, and 
anesthesiology. It’s high accuracy and absence of radiation exposure surpasses its 
confinements as a non-panoramic imaging modality compared to chest roentgenogram 
or computed tomography in the daily management of patients.  
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Variability of practitioner knowledge and lack in standardized training are 
challenges to the expanded use of LUS. To address these concerns, the American 
College of Chest Physicians (ACCP) and La Société de Réanimation de Langue 
Francaise published a joint statement on competence in critical are ultrasonography 80. 
In anesthesiology and other medical disciplines, training programs being initiated to 
ensure uniformity and consistency in education and the evaluation of proficiency for the 
use of ultrasound 81,82.  
 
Transpulmonary Thermodilution: 
Transpulmonary thermodilution uses a cold indicator delivered into a central vein 
and detected by a thermistor tipped catheter in the aorta (either in the femoral or axillary 
arteries) resulting in recording of a thermodilution curve. A variety of physiologic 
parameters including cardiac output, intrathoracic volumes, and extravascular lung 
water are obtained from this curve. The presence of pulmonary edema results in a heat 
sink with increased indicator loss (i.e. warming of the fluid bolus) during pulmonary 
transit. This loss of indicator is used to quantify extravascular lung water. The 
calculation of EVLW using the TPTD method is beyond the scope of this review. A 
detailed review of this technique is available in our previous publication 3. As such, 
clinical measurement of EVLW reflects a morphologic correlate of pulmonary edema 83.  
Compelling evidence supports the ability of TPTD to characterize progressive 
accumulation of pulmonary edema. In a porcine model of hydrostatic pulmonary edema, 
Bongard et al demonstrated the association between EVLW and the classical 
histological progression of pulmonary edema 83. EVLW measurements has strong linear 
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association with increases in perivascular cuff width to vessel diameter ratio (r=0.87; 
p<0.0001), inter-alveolar septal width (r=0.89; p<0.001) and (once present) alveolar 
flooding (r=0.87; p<0.001) 83. 
The sensitivity of TPTD to detect early and small changes in pulmonary edema is 
another strong asset to this modality.  Fernandez-Mondejar et al examined the ability of 
TPTD EVLW measurement to detect ‘small changes’ in EVLW in pigs both with and 
without pulmonary edema 84. By measuring EVLW immediately before and after 
intratracheal administration of 50 ml of saline solution [so increasing EVLW (alveolar 
fluid) by 50ml], they demonstrated that TPTD could detect these modest increases in 
EVLW. Putting these results in context with the observations of Bongard et al 83 which 
suggest that increases in EVLW in excess of 100% are required before the onset of 
hypoxemia or histological changes, makes the exciting suggestion that EVLW 
measurement may be able to sensitively detect sub-clinical increases in EVLW, 
potentially facilitating early intervention. 
Several authors have demonstrated modest association between chest 
roentgenogram scores and TPTD derived EVLW 85-87. The existence of only modest 
association between two modalities, ostensibly measuring the same thing, may reflect 
the superior sensitivity and specificity of EVLW measurement; increased chest 
roentgenogram opacity is not specific to the existence of pulmonary edema, whilst the 
superior sensitivity of TPTD for small increases in EVLW means that EVLW may exist, 
be measureable by TPTD but undetectable by chest roentgenogram. 
Another major advantage of the TPTD technique to measure pulmonary edema over 
imaging modalities is its inherent reproducibility. Both TPTD monitors available for 
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clinical use (Figure 10) 88, 89 achieve values for the co-efficient of variation (CV) of 
EVLW ranging from 4.8 to 8% 90, 91; well within the 15% threshold of CV which has been 
suggested as a cut-off for clinical acceptability 92. In practice, manual inspection of 
thermodilution curves at the time of measurement allows clearly spurious 
measurements to be discarded and adds further increased reliability. 
TPTD requires central venous and arterial cannulation, limiting hospital wide 
application of the technique. In patients in intensive care or during the perioperative 
period where invasive monitoring is commonplace however, TPTD derived EVLW 
measurement has many benefits. Once TPTD monitoring is established, junior medical 
or non-medical staff with the minimum of training may easily and rapidly perform a 
series of thermodilution measurements. This ease of use and the absence of ionizing 
radiation means EVLW can be repeatedly determined multiple times a day, allowing 
trends to be observed and an evaluation of response to therapy is monitored. 
In addition to providing an index of the presence and severity of pulmonary edema, 
TPTD also offers the potential to aid the clinician in determining the etiology of edema. 
Measurement of EVLW in the context of cardiac preload 93 (i.e. calculation of the ratio of 
EVLW to cardiopulmonary blood volume can provide a means to estimate pulmonary 
vascular permeability. Intrathoracic blood volume (ITBV) 93-95, global end-diastolic 
volume (GEDV) 94, 96 and pulmonary blood volume (PBV) 94-96 are indices of cardiac 
preload derived from TPTD to which EVLW has been indexed in the derivation of  
‘pulmonary vascular permeability indices’ (PVPIs). The concept is intuitive; a high 
EVLW in a hypovolemic patient (and therefore an elevated ratio) suggests increased 
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capillary permeability as the primary pathology whilst high EVLW in a patient with 
elevated preload (normal ratio) suggests increased hydrostatic forces.  
TPTD methods for measuring EVLW can only measure lung water in perfused areas 
of lung and so rely upon a homogeneous distribution of pulmonary perfusion to 
accurately determine EVLW. A large perfusion deficit will lead to underestimation of 
EVLW. Regional pulmonary perfusion is influenced by many factors pertinent to the 
perioperative critically ill population. Hypoxic pulmonary vasoconstriction 97, lung injury 
98, vascular obstruction 99, positive end-expiratory pressure 100, 101, spontaneous 
breathing 102 and lung resection 103 can all influence ventilation-perfusion relationships 
and so lead to errors in the estimation of EVLW. 
It is plausible that the presence of pleural or pericardial effusions could provide a 
further extravascular fluid volume into which cold indicator could distribute, leading to an 
artefactual over-estimate of the EVLW volume. Blomqvist et al systematically evaluated 
the effects of incremental increases in pleural fluid volume (warmed normal saline 
introduced bilaterally via intercostal catheters) on EVLW in otherwise healthy dog lungs. 
They reported a slight, but not statistically significant rise in EVLW and though “a minor, 
and for practical purposes negligible loss of thermal indicator to the pleural fluid could 
not be excluded”, they ultimately concluded that installation of up to 20 ml/kg of fluid into 
the pleural cavity has no effect on EVLW 104. Similarly, several clinical studies in 
medical intensive care patients undergoing thoracentesis have demonstrated no effect 
of pleural effusion on EVLW measurement 105, 106. 
 In summary, EVLW together with other TPTD derived parameters offers an 
insight to clinicians to explore and portray patient’s hemodynamic instability in depth.  
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TPTD derived EVLW offers a unique means to quantify and early diagnose pulmonary 
edema, track the progression and response to therapy and help differentiate its etiology. 
Its relative invasive nature limits its use to hemodynamically unstable patients in the 
intensive care units or to the operating room to patients undergoing surgeries that carry 
a high risk for lung injury e.g. major cardiothoracic and vascular surgery. 
  
Modality Selection: 
In current practice the practitioner’s selection amongst auscultation, chest 
roentgenogram, lung ultrasound, and transpulmonary thermodilution to assess 
pulmonary edema is influenced by clinical and institutional factors. The demands of the 
case at hand, along with the expertise and resources available in the clinical setting 
dictate the modality employed. To aid in this selection process, the advantages and 
limitations of the various modalities in the clinician’s armamentarium are summarized in 
Table 4.    
Stethoscopy remains an important component of the initial clinical examination.  
As a tool, it shows high specificity but at the cost of low sensitivity, lacking in early 
detection of pulmonary congestion with a limited ability to inform on the severity of 
pulmonary edema. As such it is recommended primarily as a readily available and 
inexpensive screening tool. 
Chest roentgenography remains the modality of choice in post anesthesia care 
units and intensive care units to initially diagnose, profile the etiology, and subsequently 
monitor patients with pulmonary edema. Its panoramic view of the chest helps clinicians 
identify additional pulmonary pathologies co-existing with pulmonary edema.  
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To avoid clinical errors, clinicians must remain cognizant of the limited accuracy of chest 
roentgenogram for both early detection and grading of the severity of EVLW 
accumulation. As such, chest roentgenogram is another modality with high specificity 
and low sensitivity. Further, the temporal changes in the radiographic evidence of 
pulmonary congestion lag the clinical manifestations both in its detection of the onset of 
pulmonary edema and its resolution. Despite these limitations, resource availability and 
the wealth of information provided by chest roentgenograms and the availability of 
expert radiologists for interpretation continue to support its widespread use in current 
practice. 
Lung ultrasonography is a recent advance that addresses many of the limitations 
inherited by chest auscultation and chest roentgenogram. It has the advantage of 
detection of early phases of EVLW accumulation prior to clinical manifestations allowing 
the clinician to implement clinical interventions prior to overt clinical manifestations.  Its 
property of higher specificity and sensitivity than seen with prior techniques promotes its 
use both as an initial screening modality and as a monitor.  One of its most useful 
applications is in the perioperative period for early detection of acute interstitial 
pulmonary edema especially in patients present for surgery without any preoperative 
respiratory symptoms.  Its noninvasiveness, including no ionizing radiation, has led to 
lung ultrasound frequently being used in conjunction with or as a replacement for chest 
roentgenograms. However, in contrast to chest radiography that is supported by 
specialized radiology technicians and physicians, the lack of available personnel with 
skill in performance and interpretation of lung ultrasound limits its use in many 
institutions.  This remains an educational challenge for our training institutions. 
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Invasive hemodynamic monitors are frequently required during major surgical 
procedures, such as cardiac, major vascular or thoracic surgery, or in clinical conditions 
such as septic shock that carry a high risk for lung injury. In these patients, 
transpulmonary thermodilution offers unique advantages. It provides several 
hemodynamic indices to guide therapeutic management. In addition, the ability to 
quantitatively measure EVLW accumulation at its earliest phase and assess its 
progression or improvement is particularly advantageous to these patients’ groups. As 
such, TPTD monitoring offers a combination of benefits not obtainable by other 
modalities. Recognizing that its invasiveness limits its use to select patients, the 
information provided by TPTD is currently unrivaled by competing technologies. 
 
Conclusion:    
Pulmonary edema is a long recognized morbid condition.  In response, the past 
two centuries have witnessed the development of a series of technological approaches 
for its detection and monitoring.  Today’s clinician benefits from an armamentarium of 
devices to assess lung water, each of which best suited to a particular application.  The 
selection of modality for the case at hand requires not only an understanding of the 
unique advantages and limitations of these approaches but also on the availability of 
expertise in their application and interpretation. 
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Figures and video Legends: 
Figure 1:  
Electron microscopy reveals vascular capillary in cross section and its associated 
endothelial glycocalyx layer. (Adapted from Rehm et al.19). 
Figure 2:  
A- An intact endothelial glycocalyx covers the luminal endothelial surface and cell-
cell junctions limiting water and electrolyte efflux. 
B- Breakdown of the glycocalyx layer, such as seen following surgery or 
ischemic/reperfusion injury, results in increased vascular permeability and 
pulmonary edema. 
 (Adapted from Collins et al. 17). 
Figure 3 
Laënnec’s stethoscope.  
A) Photo courtesy of the US National Library of Medicine.  
1) Instrument assembled 
2) and 3) two portions of the instrument in longitudinal section  
4) Detachable chest piece 
5) Ear piece unscrewed;  
6) Transverse section. 
B.  Laënnec and the Stethoscope. Painting by Robert A.Thom (1915-1979), c.1960. 
 (Adapted from Roguin A. 29). 
Figure 4: 
Classification of pulmonary crackles.  
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ll Time in milliseconds from the onset of the crackle until the first deflection returns to 
the baseline. (Adapted from Andrews J and Badger T. 31). 
Figure 5:  
Chest roentgenogram features of cardiogenic pulmonary edema.  
Figure 6: 
Chest roentgenogram features of acute respiratory distress syndrome showing patchy 
opacities, the indistinct vessels signify interstitial edema, while the airspace disease 
signifies alveolar edema. 
Figure 7: 
Normal lung ultrasound.  
A) A-lines reverberation artifact in equal distance (arrows).  
B) B-lines (stars) arising as well-defined echogenic comet tail from the pleural line 
throughout the entire US image. LUS = lung ultrasound. 
Figure 8: 
CXR and LUS of normal lung and AIS.  
A) Normal AP-CXR. B) CXR in mild AIS. C) CXR in severe AIS. D) US findings of 
normal lung tissue with A-lines (arrows) and B-line (star), smooth pleural interface and 
homogenous lung tissue. E) US findings of mild interstitial pulmonary edema with lung 
rockets (stars). F) US findings in severe AIS with ground glass rockets or “white Lung”, 
with persistent smooth pleural line and homogeneous lung tissue suggestive of severe 
pulmonary edema secondary to APE.  
CXR= chest radiography, AP = anteroposterior, LUS = lung ultrasound,  
AIS = alveolar-interstitial syndrome, APE = acute cardiopulmonary edema. 
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Figure 9: 
Lung ultrasound of alveolar interstitial syndrome. Acute cardiogenic edema vs ARDS.  
A) Lung ultrasound findings suggestive of alveolar interstitial syndrome secondary to 
acute cardiogenic edema include: ground glass rockets or “white Lung”, with persistent 
smooth pleural line and homogeneous lung tissue.  
B) Lung ultrasound findings suggestive of alveolar interstitial syndrome secondary to 
severe ARDS include: “white lung” in combination with thickened and uneven pleural 
line, inhomogeneous lung tissue and air bronchograms (arrows)  
ARDS = adult respiratory distress syndrome. 
Figure 10: 
Screenshots from 2 proprietary transpulmonary thermodilution systems commercially 
available. A) The PiCCO2 system (Pulsion Medical Systems SE, Munich, Germany) and 
B) The VolumeView/EV1000 system (Edwards Life sciences, Irvine CA).   
CI = Cardiac index, ELWI = Extravascular lung water index, GEDI = global end diastolic 
index, PCCI = Pulse contour cardiac index, ScVo2 = Mixed venous oxygen saturation, 
SVI = Stroke volume index, SVV = Stroke volume variation. 
Video 1: 
Two-dimensional ultrasound imaging of lung sliding in the normal lung. The pleural 
line can be seen as a fine horizontal echogenic line in the center of the image. Vertical 
artifacts with characteristics of B-lines arise from the pleural line. They are long non-
fading, well-defined, hyperechoic comet-tail artifacts that move with lung sliding. An 
A-line being “erased” by the B-line can be seen at the bottom of the image. 
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